Journal · Cardiology · Updated 15 November 2026
JAMA Cardiology
Read JAMA Cardiology research on DeepDyve. No university library needed.
JAMA Cardiology, published by the American Medical Association since 2016, covers clinical research on diseases of the heart and blood vessels. Its papers range from coronary artery disease and atrial fibrillation to cardiac arrest and the heart health of people treated for cancer. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including the American Medical Association.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
JAMA Cardiology at a glance
- Full title
- JAMA Cardiology
- Abbreviation (NLM)
- JAMA Cardiol
- Publisher
- American Medical Association
- Print ISSN
- 2380-6583
- Online ISSN (eISSN)
- 2380-6591
- First published
- 2016
- Subjects
- Cardiology
- Access model
- Subscription
- On DeepDyve
- Research articles; availability varies by article
Ways to access JAMA Cardiology
JAMA Cardiology is a subscription journal. To read its articles, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- The authors’ accepted manuscript. JAMA Network lets authors post the accepted manuscript of original research in a repository of their choice on the day of publication. Search the title in PubMed Central, Google Scholar or the authors’ university repository.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to JAMA Cardiology. Check its journal list and whether it offers remote access.
- DeepDyve. Read JAMA Cardiology articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: AMA on JAMA Network’s manuscript policy; NIH Public Access Policy.
Recent JAMA Cardiology research worth reading
Published May to August 2026. Summaries describe what the authors report.
-
Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification
In a randomized clinical trial of 180 adults, the authors report that menaquinone-7 significantly slowed the progression of coronary artery calcification compared with placebo, and say a large prospective trial with hard clinical outcomes is needed to tell whether supplementation is beneficial.
JAMA Cardiology, June 2026 · DOI 10.1001/jamacardio.2026.1279
-
Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention
In a systematic review and meta-analysis of P2Y12 inhibitors after percutaneous coronary intervention, the authors found a lower risk of major adverse cardiovascular events with prasugrel than with clopidogrel or ticagrelor, and a higher risk of major bleeding with ticagrelor than with clopidogrel.
Maqsood et al. · JAMA Cardiology, published online July 1, 2026 · DOI 10.1001/jamacardio.2026.1128
-
Catheter-Based Left Atrial Appendage Closure vs Oral Anticoagulation in Patients With Atrial Fibrillation
Pooling 8 randomized clinical trials, the authors found that catheter-based left atrial appendage closure had similar rates of stroke and major bleeding to oral anticoagulation at a weighted mean follow-up of 37.9 months, with a higher risk of ischemic stroke and a lower risk of nonprocedural major bleeding.
JAMA Cardiology, August 2026 · DOI 10.1001/jamacardio.2026.2640
-
Resuscitation Quality Improvement Program for CPR Training and Cardiac Arrest Survival in Hospitals
Comparing 18 hospitals that adopted the Resuscitation Quality Improvement program for quarterly CPR training with 107 control hospitals, the authors found no improvement in survival to discharge or return of spontaneous circulation after in-hospital cardiac arrest in the 2 years after implementation.
JAMA Cardiology, May 2026 · DOI 10.1001/jamacardio.2026.1074
-
Cardiovascular Health Across the Life Course for Individuals With Breast Cancer
This review covers cardiovascular health in people with breast cancer, noting that several therapies are associated with cardiovascular adverse effects and that, for long-term survivors, those effects can pose a greater threat to overall long-term health than the cancer itself.
JAMA Cardiology, July 2026 · DOI 10.1001/jamacardio.2026.2546
Related journals
Questions about JAMA Cardiology
How can I read JAMA Cardiology articles without a subscription?
JAMA Network lets authors post the accepted manuscript of original research in a repository of their choice on the day of publication. Search the title in PubMed Central, Google Scholar or the authors’ university repository. Your library may also subscribe. DeepDyve lets you read JAMA Cardiology articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for JAMA Cardiology?
JAMA Cardiology’s NLM (PubMed) abbreviation is JAMA Cardiol.
What is the ISSN of JAMA Cardiology?
The print ISSN is 2380-6583 and the online ISSN is 2380-6591.
Is JAMA Cardiology open access?
JAMA Cardiology articles are published under the subscription model; none of the 311 articles it published from January 1 to November 14, 2026 carry a Creative Commons license in Crossref.
JAMA Cardiology articles on DeepDyve are licensed from the American Medical Association. Journal facts as of 15 November 2026.
Start reading JAMA Cardiology today
One month free, then less than $2 a day. JAMA Cardiology, plus millions of articles from thousands of journals.




